Description

(20ξ)-3,3-[1,2-Ethanediylbis(Oxy)]-20-Hydroxy-23-Oxo-5α-Lanost-9(11)-En-18-Oic Acid γ-Lactone is a high-purity, semi-synthetic lanostane derivative, a critical intermediate in advanced pharmaceutical synthesis. This compound matters for its role as a key precursor in the development of novel therapeutic agents, particularly in steroid and triterpenoid chemistry. It is essential for R&D and production teams in the pharmaceutical, biotechnology, and fine chemical sectors who require reliable, high-quality building blocks for complex molecule synthesis.

Application

• Pharmaceutical Intermediate: A crucial precursor in the synthesis of novel steroid-based drugs and therapeutic triterpenoids.
• Biochemical Research: Used as a reference standard or starting material in studies of lanostane biosynthesis and enzyme inhibition.
• Fine Chemical Synthesis: Serves as a sophisticated building block for constructing complex molecular architectures in medicinal chemistry.
• API Development: Employed in the research and development of new Active Pharmaceutical Ingredients (APIs) targeting metabolic and inflammatory pathways.
• Academic Research: Utilized in university and institutional labs for investigating structure-activity relationships (SAR) of natural product derivatives.

Basic Information

Product Name	(20ξ)-3,3-[1,2-Ethanediylbis(Oxy)]-20-Hydroxy-23-Oxo-5α-Lanost-9(11)-En-18-Oic Acid γ-Lactone
CAS No.	36871-83-7
Molecular Formula	C32H46O7
Molecular Weight	542.71 g/mol
Synonyms	3,3-Ethanediylbis(oxy)-20-hydroxy-23-oxo-5α-lanost-9(11)-en-18-oic acid γ-lactone; 20-Hydroxy-23-oxo-5α-lanost-9(11)-en-18,20-olide 3,3-ethylenedioxy derivative; Lanostane γ-lactone derivative; 3,3-Ethylenedioxy-20-hydroxy-23-oxolanost-9(11)-en-18-oic acid lactone; (20ξ)-3,3-[1,2-Ethanediylbis(oxy)]-20-hydroxy-23-oxo-5α-lanost-9(11)-en-18-oic acid γ-lactone
EINECS	Contact for details

Quality Control

Our (20ξ)-3,3-[1,2-Ethanediylbis(Oxy)]-20-Hydroxy-23-Oxo-5α-Lanost-9(11)-En-18-Oic Acid γ-Lactone is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC and NMR, to ensure high purity and structural integrity suitable for pharmaceutical R&D. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are available upon request to support your quality and regulatory documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.